Most cancer patients experience multiple symptoms related to chemotherapy and use CAM (complementary and alternative medicine) as an adjunct to conventional treatment. Moxibustion is traditional Korean medical therapeutic method and uses the heat generated by burning herbal preparations containing Artemisia vulgaris to stimulated acupoint.

Herein, the investigators propose an open-label pilot study investigating the effectiveness of moxibustion stimulation at abdominal acupoint on quality of life in cancer patients under chemotherapy.

Inclusion Criteria:

• Diagnostic histopathology of cancer
• Performance status of 0-2 on the European Cooperative Oncology Group (ECOG) performance scale.
• Patients on chemotherapy currently have plan to receive chemotherapy for more than 6 weeks.
• Follow-up possible during the clinical trial
• Informed signed consent

Exclusion Criteria:

• Patients with Severe Heart disease and hypertension that is not controlled (systolic blood pressure >160 or Diastolic blood pressure >100)
• Patients with diabetes that is not controlled (FBST >180 or BST>250)
• Patients with abdominal injury or severe ascites can't be received moxibustion therapy on abdomen.
• Hypersensitive section to moxibustion treatment
• Inability to comprehend or express oneself in the Korean language
• An Individual deemed to be ineligible by a physician
• Refusal to participate in this trial or to provide informed consent.